Sign in

    Steven L. Martin

    Research Analyst at Slater Capital Management LLC

    Steven L. Martin is an analyst at Slater Capital Management LLC, specializing in equity research with a focus on mid-cap technology and healthcare companies. He has covered firms such as Teladoc Health, Okta, and Datadog, and is recognized for delivering an above-market success rate of 62% on his published recommendations with an average portfolio return of 13% over three years. Martin began his financial services career in 2009 at Prudential before joining Slater Capital Management in 2017, where he holds the full title of Senior Equity Analyst. He is FINRA-registered with active Series 7 and 63 licenses, and has been acknowledged on industry platforms for his consistent accuracy in fundamental analysis.

    Steven L. Martin's questions to PTMN leadership

    Steven L. Martin's questions to PTMN leadership • Q2 2025

    Question

    Steven L. Martin questioned what the most significant changes to the pro forma combined portfolio would be after the Logan Ridge merger, whether the number of unique portfolio companies would materially change, and if there were any updates on the remaining equity positions from the Logan Ridge portfolio.

    Answer

    CIO Patrick Schafer explained that the portfolios are quite similar, so changes won't be dramatic, but from Portman's perspective, the mix of pure debt will likely increase slightly while CLO equity and joint venture percentages will decrease. He noted the number of unique borrowers would increase by about 10-15 names. CFO Brandon Satoren added that while yields are similar, the combined entity will benefit from material operating expense efficiencies.

    Ask Fintool Equity Research AI